Prise en charge des infections des voies respiratoires basses de l'immunocompétent. Partie concernant les définitions, l'épidémiologie et les éléments du diagnostic. Médecine et Maladies Infectieuses, pp.11-12784, 2006. ,
PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY, The Lancet, vol.329, issue.8534, pp.671-675, 1987. ,
DOI : 10.1016/S0140-6736(87)90430-2
Diagnostic value of lung auscultation in an emergency room setting, Swiss Med Wkly, vol.135, pp.35-36520, 2005. ,
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults, Clinical Infectious Diseases, vol.44, issue.Supplement 2, pp.27-72, 2007. ,
DOI : 10.1086/511159
Community-Acquired Pneumonia: An Unfinished Battle, Medical Clinics of North America, vol.95, issue.6, pp.1143-61, 2011. ,
DOI : 10.1016/j.mcna.2011.08.007
Severe Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.166, issue.5, pp.717-740, 2002. ,
DOI : 10.1164/rccm.2102084
Predictive factors, microbiology and outcome of patients with parapneumonic effusion, European Respiratory Journal, vol.38, issue.5, pp.1173-1182, 2011. ,
DOI : 10.1183/09031936.00000211
The definitions and epidemiology of pleural space infection, Semin Respir Infect, vol.14, issue.1, pp.3-8, 1999. ,
Parapneumonic Pleural Effusion and Empyema in Children: Review of a 19-Year Experience, 1962-1980, Clinical Pediatrics, vol.22, issue.6, pp.414-423, 1983. ,
DOI : 10.1177/000992288302200603
Emergence of parapneumonic empyema in the USA, Thorax, vol.66, issue.8, pp.663-671, 2011. ,
DOI : 10.1136/thx.2010.156406
An Epidemiological Investigation of a Sustained High Rate of Pediatric Parapneumonic Empyema: Risk Factors and Microbiological Associations, Clinical Infectious Diseases, vol.34, issue.4, pp.434-474, 2002. ,
DOI : 10.1086/338460
Nonsteroidal Antiinflammatory Drugs May Affect the Presentation and Course of Community-Acquired Pneumonia, Chest, vol.139, issue.2, pp.387-94, 2011. ,
DOI : 10.1378/chest.09-3102
The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation, Clinical Infectious Diseases, vol.47, issue.S3, pp.133-139, 2008. ,
DOI : 10.1086/591394
Validation of a predictive rule for the management of community-acquired pneumonia, European Respiratory Journal, vol.27, issue.1, pp.151-158, 2006. ,
DOI : 10.1183/09031936.06.00062505
Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis, Thorax, vol.65, issue.10, pp.884-90, 2010. ,
DOI : 10.1136/thx.2009.134072
The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study, Archives of Internal Medicine, vol.157, issue.1, pp.36-44, 1997. ,
DOI : 10.1001/archinte.157.1.36
Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia, Thorax, vol.64, issue.7, pp.592-599, 2009. ,
DOI : 10.1136/thx.2008.105080
Thoracic Empyema in Patients with Community-Acquired Pneumonia, The American Journal of Medicine, vol.119, issue.10, pp.877-83, 2006. ,
DOI : 10.1016/j.amjmed.2006.03.042
Treatment failure in community-acquired pneumonia. Chest, pp.1348-55, 2007. ,
Prostaglandins E as modulators of the immune response, Lymphokine Res, vol.7, issue.3, pp.237-282, 1988. ,
Aspirin and immune system, International Immunopharmacology, vol.12, issue.1, pp.10-20, 2012. ,
DOI : 10.1016/j.intimp.2011.11.021
Prostaglandin E2 Inhibits Alveolar Macrophage Phagocytosis through an E-Prostanoid 2 Receptor-Mediated Increase in Intracellular Cyclic AMP, The Journal of Immunology, vol.173, issue.1, pp.559-65, 2004. ,
DOI : 10.4049/jimmunol.173.1.559
Management of lower respiratory tract infections by French general practitioners: the AIR II study, European Respiratory Journal, vol.19, issue.2, pp.314-323, 2002. ,
DOI : 10.1183/09031936.02.00219102
Risks of nonsteroidal antiinflammatory drugs in undiagnosed intensive care unit pneumococcal pneumonia: Younger and more severely affected patients, Journal of Critical Care, vol.29, issue.5, pp.733-741, 2014. ,
DOI : 10.1016/j.jcrc.2014.05.021
Prevalence and risk factors of suppurative complications in children with pneumonia, Acta Paediatrica, vol.25, issue.6, 2010. ,
DOI : 10.1111/j.1651-2227.2010.01734.x
Risk factors for the development of pleural empyema in children, Pediatric Pulmonology, vol.13, issue.7, pp.721-727 ,
DOI : 10.1002/ppul.23041
Hospitalization for Severe Bacterial Infections in Children after Exposure to NSAIDs, Clinical Drug Investigation, vol.27, issue.3, pp.179-85, 2010. ,
DOI : 10.2165/11532890-000000000-00000
Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs, Clinical and Experimental Dermatology, vol.135, issue.3, pp.249-55, 2008. ,
DOI : 10.1016/S0755-4982(04)98821-5
A multicentre case-control study of nonsteroidal anti-inflammatory drugs as a risk factor for severe sepsis and septic shock, Critical Care, vol.13, issue.2, p.43, 2009. ,
DOI : 10.1186/cc7766
URL : https://hal.archives-ouvertes.fr/inserm-00533142
Possible role of anti-inflammatory drugs in complications of pharyngitis. A retrospective analysis of 163 cases. Eur Ann Otorhinolaryngol Head Neck Dis, pp.299-303, 2014. ,
Assessing the Relationship Between the Use of Nonsteroidal Antiinflammatory Drugs and Necrotizing Fasciitis Caused by Group A Streptococcus, Medicine, vol.82, issue.4, pp.225-260, 2003. ,
DOI : 10.1097/01.md.0000085060.63483.bb
A Case-Control Study of Necrotizing Fasciitis During Primary Varicella, PEDIATRICS, vol.103, issue.4, pp.783-90, 1999. ,
DOI : 10.1542/peds.103.4.783
Diagnosing Pneumonia by Medical History and Physical Examination, Annals of Emergency Medicine, vol.46, issue.5, pp.465-472, 2005. ,
DOI : 10.1016/j.annemergmed.2005.08.011
Influence de la prise pr??alable d???anti-inflammatoires non st??ro??diens sur la pr??sentation et l?????volution de pneumonies aigu??s communautaires hospitalis??es, Revue des Maladies Respiratoires, vol.32, pp.2015-2029 ,
DOI : 10.1016/j.rmr.2014.11.039
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease, New England Journal of Medicine, vol.356, issue.8, pp.775-89, 2007. ,
DOI : 10.1056/NEJMoa063070
Influence of Previous Use of Inhaled Corticoids on the Development of Pleural Effusion in Community-acquired Pneumonia, American Journal of Respiratory and Critical Care Medicine, vol.187, issue.11, pp.1241-1249, 2013. ,
DOI : 10.1164/rccm.201209-1732OC
Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study*, Critical Care Medicine, vol.33, issue.5, pp.952-61, 2005. ,
DOI : 10.1097/01.CCM.0000162381.24074.D7
Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICU. Scand, J. Infect. Dis, vol.27, issue.3, pp.201-207, 1995. ,